PDS Biotechnology Corp (PDSB): PRINCETON, N.J., July 31, 2024 (GLOBE NE...

Next 10 Prev Next

Send PM Follow Ignore

Followers	49
Posts	4504
Boards Moderated	0
Alias Born	03/20/2012

James salmon

Re: None

Wednesday, 07/31/2024 5:48:48 PM

Wednesday, July 31, 2024 5:48:48 PM

PRINCETON, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today announced that the Company will host a conference call to provide a clinical program update on Thursday, August 1, 2024, at 8:00 a.m. ET.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent PDSB News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:07:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:05:28 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 04:26:02 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/29/2026 04:15:10 AM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/28/2026 08:30:50 PM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 04/27/2026 03:51:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2026 08:05:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 12:55:12 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:39:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 11:05:29 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:47:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:47:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:47:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:47:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:47:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:47:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:47:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 11:47:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 05:01:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:05:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 01:35:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 01:50:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 01:50:53 PM
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 • PR Newswire (Canada) • 01/12/2026 03:35:00 PM
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 • PR Newswire (US) • 01/12/2026 03:35:00 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent PDSB News

More PDSB News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent PDSB News

Go Ad-Free